Retrospective analysis of the clinical features of 172 patients with BCR-ABL1 -negative chronic myeloproliferative neoplasms

Table 2 Distribution of driven gene mutations (n(%))

Disease	JAK2-V617 mutation	Non-JAK2-V617 mutation				No driven gene mutations
Disease	JAK2-V617 mutation	CALR	MPL	JAK2-12exon	EZH2	No driven gene mutations
PMF	15(62.5)	1(4.2)	1(4.2)	0	1(4.2)	6(25)
PV	73(91.3)	0	0	1(1.3)	0	6(7.5)
ET	47(69.1)	8(11.8)	0	0	0	13(19.1)

ISSN: 1755-8166